.jpg)
.png)
Winter 2014 2015
I have in mind a prospective clinical trial in which I study a common children’s phenomenon, detailing the differences between genders, location, ethnicity, biometrics, dental data, monetary value, etc. It’s a common phenomenon that most parents have photos of and have experienced ourselves. I’m... more
This issue sponsored by the Southeast Lipid Association Featuring: "Translating Clinical Trial Evidence into Practical Medicine" and "Guidelines for the Guidelines — Impact and Controversies" more
“Security is mostly a superstition. It does not exist in nature, nor do the children of men as whole experience it. Avoiding danger is no safer in the long run than outright exposure. Life is either a daring adventure or nothing.” – Helen Keller This quote is a favorite of Deborah S. Croy, DNP.... more
I hope everyone had a wonderful Holiday Season and a Happy New Year! To kick off the New Year, the Foundation of the National Lipid Association (FNLA) is hard at work with new projects and partnerships. Most recently, the FNLA collaborated with Sanofi US and Regeneron Pharmaceuticals Inc. in... more
Greetings, National Lipid Association members! I hope this holiday season has been a joyous one. As we look back on 2014, we can reflect on the many accomplishments the NLA has put forth. And, as we look toward the New Year, we are encouraged for what’s to come — both for the NLA as a... more
I am honored and excited to serve as President of the Southeast Lipid Association (SELA). My passion for lipids heralds back to the formation of the Florida Lipid Associates in 1994, led by Paul Ziajka, MD, PhD, FNLA, and some others interested in lipid research and treatment. It has been... more
I write this with the holiday season having just passed us. As I sit back and reflect on the past year, it occurs to me that we have much to be thankful for! This past year we embraced the extensive statin safety report from the National Lipid Association. This was followed in September by the... more
Over the course of my 36-year career, the practice of medicine has changed dramatically. When I was an intern at Georgetown University Hospital, we treated heart attacks with oxygen, morphine, and sometimes not much more than prayers. Barely anyone at that time could conceive of doing a cardiac... more
This issue of LipidSpin is dedicated to “Evaluating Published Clinical Trials and Translating Them into Practice.” Clinical trials are the basis for advancing our knowledge of effective therapies in medicine. Well-conducted clinical trials, particularly those with results that can be replicated,... more
The Heart Protection Study 2 — Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) trial was a randomized, double-blind, multicenter clinical trial.1 Enrolled subjects were between ages 50 and 80 and had a history of vascular disease. After a four-week run-in phase with... more